Black Rock Inc. Agios Pharmaceuticals, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,859,002 shares of AGIO stock, worth $172 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,859,002
Previous 4,658,095
4.31%
Holding current value
$172 Million
Previous $136 Million
53.83%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AGIO
# of Institutions
232Shares Held
58.1MCall Options Held
403KPut Options Held
469K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$200 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.55MShares$196 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$132 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$100 Million0.01% of portfolio
-
State Street Corp Boston, MA2.33MShares$82.4 Million0.0% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.94B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...